Dr. Boomershine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3100 Duraleigh Road
Suite 304
Raleigh, NC 27612Phone+1 919-781-2514Fax+1 919-420-6067
Summary
- Dr. Chad Boomershine is VP of Clinical Affairs for M3 Wake Research, a clinical trials network conducting clinical research trials in various indications across the United States. Dr. Boomershine received his medical and PhD degrees from The Ohio State University and completed an Internal Medicine residency and Rheumatology Fellowship at Vanderbilt University.
Education & Training
- Vanderbilt University Medical CenterFellowship, Rheumatology, 2004 - 2008
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2002 - 2004
- Ohio State University College of MedicineClass of 2002
Certifications & Licensure
- NM State Medical License 2022 - 2026
- IL State Medical License 2022 - 2026
- OH State Medical License 2022 - 2026
- AZ State Medical License 2022 - 2025
- NJ State Medical License 2022 - 2025
- NC State Medical License 2022 - 2025
- NV State Medical License 2022 - 2025
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pain Medicine
- National Board of Physicians and Surgeons Rheumatology
- American Board of Pain MedicineBoard Certified Pain Medicine
- Association of Clinical Research ProfessionalsCertified Principal Investigator
- Join now to see all
Clinical Trials
- A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- 22 citationsA Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia.Chad S. Boomershine, Todd A. Koch, David Morris
Rheumatology and Therapy. 2018-06-01 - 56 citationsFibromyalgia: The Prototypical Central Sensitivity SyndromeChad S Boomershine
Current Rheumatology Reviews. 2015-07-31 - 27 citationsTime course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohortLiana D. Castel, Katherine E Hartmann, Ingrid A. Mayer, Benjamin R. Saville, JoAnn Alvarez
Cancer. 2013-07-01
Grant Support
- Mechanisms Of Dendritic Cell Tolerance In Autoimmune PancreatitisNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
Professional Memberships
- Member
- Tennessee Rheumatology SocietyPresident
- Clinical Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: